Aerosol Environmental Regulations – SOP Guide for Pharma https://www.pharmasop.in The Ultimate Resource for Pharmaceutical SOPs and Best Practices Mon, 28 Jul 2025 20:33:00 +0000 en-US hourly 1 Aerosol: SOP for Managing Retained Samples of Aerosol Products – V 2.0 https://www.pharmasop.in/aerosol-sop-for-managing-retained-samples-of-aerosol-products-v-2-0/ Mon, 28 Jul 2025 20:33:00 +0000 https://www.pharmasop.in/?p=8871 Read More “Aerosol: SOP for Managing Retained Samples of Aerosol Products – V 2.0” »

]]>
Aerosol: SOP for Managing Retained Samples of Aerosol Products – V 2.0

Procedure for Managing Retained Samples of Aerosol Products

Department Aerosol
SOP No. SOP/Aerosol/200/2025
Supersedes SOP/Aerosol/200/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define a systematic approach for the storage, monitoring, and disposal of retained samples of aerosol products to ensure product quality, traceability, and regulatory compliance.

2. Scope

This SOP applies to all retained samples of finished aerosol products stored in the Quality Control (QC) laboratory or designated retention areas.

3. Responsibilities

  • Quality Control (QC) Analysts: Responsible for managing retained samples as per storage conditions.
  • Quality Assurance (QA) Team: Responsible for periodic review and audit of retained sample inventory.
  • Warehouse Team: Responsible for maintaining proper storage conditions.
  • Regulatory Affairs Team: Responsible for compliance with regulatory requirements.

4. Accountability

The Quality Control Manager is accountable for ensuring proper retention, monitoring, and disposal of retained samples as per regulatory guidelines.

5. Procedure

5.1. Sample Selection and Retention Criteria

  1. Select representative retained samples from each production batch.
  2. Ensure retained samples include different packaging configurations.
  3. Record sample details in the Retained Sample Log (Annexure-1).

5.2. Storage Conditions

  1. Store retained samples under controlled conditions (e.g., 25°C/60% RH).
  2. Maintain segregation of retained samples from active production stock.
  3. Record storage conditions in the Retained Sample Storage Log (Annexure-2).

5.3. Periodic Review and Monitoring

  1. Conduct periodic checks on retained sample integrity.
  2. Monitor for changes in physical appearance, pressure loss, or leakage.
  3. Record findings in the Retained Sample Monitoring Log (Annexure-3).

5.4. Disposal of Retained Samples

  1. Dispose of retained samples after the retention period (as per regulatory guidelines).
  2. Ensure safe disposal by following environmental and safety protocols.
  3. Record sample disposal details in the Retained Sample Disposal Log (Annexure-4).

5.5. Corrective Actions for Sample Deviations

  1. Investigate any observed physical or chemical changes in retained samples.
  2. Take corrective actions such as batch recall or reformulation.
  3. Record corrective actions in the Retained Sample Corrective Action Log (Annexure-5).

6. Abbreviations

  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • RH: Relative Humidity
  • SOP: Standard Operating Procedure

7. Documents

  1. Retained Sample Log (Annexure-1)
  2. Retained Sample Storage Log (Annexure-2)
  3. Retained Sample Monitoring Log (Annexure-3)
  4. Retained Sample Disposal Log (Annexure-4)
  5. Retained Sample Corrective Action Log (Annexure-5)

8. References

  • Good Manufacturing Practice (GMP) Guidelines
  • ICH Q1A Stability Testing Guidelines
  • FDA Guidance on Sample Retention

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Retained Sample Log

Batch No. Sample ID Storage Condition Checked By
BN-270 SPL-601 25°C/60% RH QA Team

Annexure-2: Retained Sample Storage Log

Sample ID Storage Location Temperature (°C) Reviewed By
SPL-601 Retention Area 1 25°C QA Team

Annexure-3: Retained Sample Monitoring Log

Sample ID Inspection Date Observations Reviewed By
SPL-601 07/02/2025 No Change QA Team

Annexure-4: Retained Sample Disposal Log

Sample ID Disposal Date Disposal Method Approved By
SPL-601 08/02/2027 Incineration QA Team

Annexure-5: Retained Sample Corrective Action Log

Issue Identified Corrective Action Implementation Date Approved By
Physical Change Observed Batch Recall 08/02/2025 Anjali Sharma

12. Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma
01/01/2025 V 2.0 Updated retention guidelines GMP Compliance Anjali Sharma
]]>
Aerosol: SOP for Validating Test Equipment for Quality Control – V 2.0 https://www.pharmasop.in/aerosol-sop-for-validating-test-equipment-for-quality-control-v-2-0/ Sun, 27 Jul 2025 23:43:00 +0000 https://www.pharmasop.in/?p=8870 Read More “Aerosol: SOP for Validating Test Equipment for Quality Control – V 2.0” »

]]>
Aerosol: SOP for Validating Test Equipment for Quality Control – V 2.0

Procedure for Validation of Test Equipment in Quality Control

Department Aerosol
SOP No. SOP/Aerosol/199/2025
Supersedes SOP/Aerosol/199/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a validated method for ensuring that all test equipment used in the Quality Control (QC) laboratory meets accuracy, reliability, and compliance standards.

2. Scope

This SOP applies to all analytical, physical, and microbiological test equipment used in aerosol quality control testing.

3. Responsibilities

  • Quality Control (QC) Analysts: Responsible for performing equipment validation.
  • Quality Assurance (QA) Team: Responsible for reviewing validation results and compliance.
  • Laboratory Supervisor: Responsible for ensuring adherence to validation procedures.
  • Regulatory Affairs Team: Responsible for compliance with regulatory validation guidelines.

4. Accountability

The Quality Control Manager is accountable for ensuring that all test equipment is properly validated and meets GMP standards.

5. Procedure

5.1. Selection of Equipment for Validation

  1. Identify all test equipment requiring validation.
  2. Ensure equipment is installed and calibrated before validation.
  3. Record equipment details in the Equipment Validation Log (Annexure-1).

5.2. Validation Protocol Development

  1. Define validation criteria such as accuracy, precision, and reproducibility.
  2. Develop test methods to evaluate equipment performance.
  3. Record protocol details in the Validation Protocol Log (Annexure-2).

5.3. Execution of Validation Studies

  1. Conduct validation tests under controlled conditions.
  2. Document performance parameters such as linearity, robustness, and specificity.
  3. Record validation results in the Validation Test Log (Annexure-3).

5.4. Analysis and Compliance Check

  1. Compare test results with predefined validation acceptance criteria.
  2. Assess if the equipment meets regulatory guidelines.
  3. Record findings in the Validation Compliance Report (Annexure-4).

5.5. Corrective Actions for Non-Compliant Equipment

  1. Investigate root causes for validation failures.
  2. Implement corrective actions such as recalibration or equipment replacement.
  3. Record corrective measures in the Validation Corrective Action Log (Annexure-5).

6. Abbreviations

  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • SOP: Standard Operating Procedure

7. Documents

  1. Equipment Validation Log (Annexure-1)
  2. Validation Protocol Log (Annexure-2)
  3. Validation Test Log (Annexure-3)
  4. Validation Compliance Report (Annexure-4)
  5. Validation Corrective Action Log (Annexure-5)

8. References

  • Good Manufacturing Practice (GMP) Guidelines
  • ICH Q2(R1) Validation of Analytical Procedures
  • ISO 17025 Laboratory Equipment Validation Standards

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Equipment Validation Log

Equipment Name Model No. Validation Date Checked By
HPLC HPLC-123 07/02/2025 QA Team

Annexure-2: Validation Protocol Log

Equipment Name Validation Parameter Protocol No. Reviewed By
UV Spectrophotometer Accuracy VAL-201 QA Team

Annexure-3: Validation Test Log

Equipment Name Test Parameter Result Reviewed By
GC-MS Precision Pass QA Team

Annexure-4: Validation Compliance Report

Equipment Name Compliance Status Approval Date Approved By
HPLC Validated 08/02/2025 QA Team

Annexure-5: Validation Corrective Action Log

Issue Identified Corrective Action Implementation Date Approved By
Precision Below Limit Recalibration 08/02/2025 Anjali Sharma

12. Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma
01/01/2025 V 2.0 Updated validation parameters GMP Compliance Anjali Sharma
]]>
Aerosol: SOP for Aerosol Emission Rate Testing – V 2.0 https://www.pharmasop.in/aerosol-sop-for-aerosol-emission-rate-testing-v-2-0/ Sun, 27 Jul 2025 02:53:00 +0000 https://www.pharmasop.in/?p=8869 Read More “Aerosol: SOP for Aerosol Emission Rate Testing – V 2.0” »

]]>
Aerosol: SOP for Aerosol Emission Rate Testing – V 2.0

Procedure for Aerosol Emission Rate Testing

Department Aerosol
SOP No. SOP/Aerosol/198/2025
Supersedes SOP/Aerosol/198/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a validated method for determining the emission rate of aerosol products to ensure consistent performance, product efficacy, and compliance with regulatory requirements.

2. Scope

This SOP applies to all aerosol products tested for emission rate in the Quality Control (QC) laboratory, as well as in-process testing during production.

3. Responsibilities

  • Quality Control (QC) Analysts: Responsible for conducting emission rate testing.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving test results.
  • Production Team: Responsible for providing representative samples for testing.
  • Regulatory Affairs Team: Responsible for ensuring compliance with global aerosol performance standards.

4. Accountability

The Quality Control Manager is accountable for ensuring the accuracy and compliance of aerosol emission rate testing.

5. Procedure

5.1. Sample Preparation

  1. Select aerosol cans randomly from the batch.
  2. Ensure samples are conditioned at room temperature before testing.
  3. Record sample details in the Emission Rate Sample Log (Annexure-1).

5.2. Testing Setup

  1. Place the aerosol can on an analytical balance.
  2. Ensure the can is positioned vertically and secured in place.
  3. Record setup details in the Testing Setup Log (Annexure-2).

5.3. Determining Aerosol Emission Rate

  1. Record the initial weight of the aerosol can.
  2. Actuate the spray for a fixed time (e.g., 10 seconds).
  3. Weigh the can immediately after spraying.
  4. Calculate the emission rate using the formula:
  5. Emission Rate (g/sec) = (Initial Weight – Final Weight) / Spray Time
  6. Record results in the Emission Rate Test Log (Annexure-3).

5.4. Data Analysis and Acceptance Criteria

  1. Compare the measured emission rate with the product specifications.
  2. Identify any deviations from acceptable limits.
  3. Document findings in the Emission Rate Analysis Report (Annexure-4).

5.5. Corrective Actions for Non-Conforming Results

  1. Investigate potential causes such as valve defects, propellant issues, or formulation inconsistencies.
  2. Implement corrective actions as required.
  3. Record corrective measures in the Emission Rate Corrective Action Log (Annexure-5).

6. Abbreviations

  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • SOP: Standard Operating Procedure

7. Documents

  1. Emission Rate Sample Log (Annexure-1)
  2. Testing Setup Log (Annexure-2)
  3. Emission Rate Test Log (Annexure-3)
  4. Emission Rate Analysis Report (Annexure-4)
  5. Emission Rate Corrective Action Log (Annexure-5)

8. References

  • Good Manufacturing Practice (GMP) Guidelines
  • ISO 16000-13 Standard for Aerosol Emissions Testing
  • FDA Guidance on Aerosol Product Performance

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Emission Rate Sample Log

Batch No. Sample ID Test Date Checked By
BN-260 SPL-501 07/02/2025 QA Team

Annexure-2: Testing Setup Log

Sample ID Setup Details Test Method Reviewed By
SPL-501 Secured on balance Weighing Method QA Team

Annexure-3: Emission Rate Test Log

Sample ID Initial Weight (g) Final Weight (g) Emission Rate (g/sec) Checked By
SPL-501 150.2 148.5 0.17 QA Team

Annexure-4: Emission Rate Analysis Report

Batch No. Emission Rate (g/sec) Specification Approved By
BN-261 0.17 0.15 – 0.20 QA Team

Annexure-5: Emission Rate Corrective Action Log

Issue Identified Corrective Action Implementation Date Approved By
Emission Rate Below Limit Valve Adjustment 08/02/2025 Anjali Sharma

12. Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma
01/01/2025 V 2.0 Updated emission rate test procedure GMP Compliance Anjali Sharma
]]>
Aerosol: SOP for Conducting Forced Degradation Studies on Aerosols – V 2.0 https://www.pharmasop.in/aerosol-sop-for-conducting-forced-degradation-studies-on-aerosols-v-2-0/ Sat, 26 Jul 2025 06:03:00 +0000 https://www.pharmasop.in/?p=8868 Read More “Aerosol: SOP for Conducting Forced Degradation Studies on Aerosols – V 2.0” »

]]>
Aerosol: SOP for Conducting Forced Degradation Studies on Aerosols – V 2.0

Procedure for Conducting Forced Degradation Studies on Aerosol Products

Department Aerosol
SOP No. SOP/Aerosol/197/2025
Supersedes SOP/Aerosol/197/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the methodology for conducting forced degradation studies on aerosol products to assess their stability, degradation pathways, and potential impact on product quality.

2. Scope

This SOP applies to all aerosol formulations subjected to forced degradation conditions, including oxidative, thermal, photolytic, and hydrolytic stress conditions.

3. Responsibilities

  • Quality Control (QC) Analysts: Responsible for conducting degradation studies.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving test results.
  • Stability Study Team: Responsible for sample selection and monitoring degradation trends.
  • Regulatory Affairs Team: Responsible for ensuring compliance with ICH stability guidelines.

4. Accountability

The Quality Control Manager is accountable for ensuring accurate degradation studies and compliance with regulatory standards.

5. Procedure

5.1. Selection of Test Samples

  1. Select representative aerosol product samples for testing.
  2. Ensure each sample is appropriately labeled and stored.
  3. Record sample details in the Forced Degradation Sample Log (Annexure-1).

5.2. Forced Degradation Conditions

  1. Apply different stress conditions:
    • Oxidative stress (H₂O₂ exposure at 3% concentration).
    • Thermal stress (60°C for 10 days).
    • Photolytic stress (UV exposure for 24 hours).
    • Hydrolytic stress (moisture exposure at 75% RH).
  2. Record degradation study conditions in the Degradation Study Log (Annexure-2).

5.3. Analytical Testing of Degraded Samples

  1. Analyze samples using HPLC, GC-MS, or spectrophotometric methods.
  2. Compare degraded samples with control samples.
  3. Document analytical results in the Degradation Analysis Report (Annexure-3).

5.4. Identification of Degradation Products

  1. Identify potential degradation by-products.
  2. Assess the toxicity and impact of degradation products on product efficacy.
  3. Record findings in the Degradation Product Identification Log (Annexure-4).

5.5. Risk Assessment and Corrective Actions

  1. Evaluate whether degradation impacts product quality.
  2. Determine if formulation modifications are required.
  3. Document corrective actions in the Degradation Study Corrective Action Log (Annexure-5).

6. Abbreviations

  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • HPLC: High-Performance Liquid Chromatography
  • GC-MS: Gas Chromatography-Mass Spectrometry
  • RH: Relative Humidity
  • ICH: International Council for Harmonisation

7. Documents

  1. Forced Degradation Sample Log (Annexure-1)
  2. Degradation Study Log (Annexure-2)
  3. Degradation Analysis Report (Annexure-3)
  4. Degradation Product Identification Log (Annexure-4)
  5. Degradation Study Corrective Action Log (Annexure-5)

8. References

  • Good Manufacturing Practice (GMP) Guidelines
  • ICH Q1A and Q1B Stability Guidelines
  • FDA Guidelines on Forced Degradation Studies

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Forced Degradation Sample Log

Batch No. Sample ID Stress Condition Checked By
BN-250 SPL-401 60°C for 10 Days QA Team

Annexure-2: Degradation Study Log

Sample ID Degradation Type Observation Period Reviewed By
SPL-401 Oxidation 10 Days QA Team

Annexure-3: Degradation Analysis Report

Batch No. Analysis Method Degradation % Reviewed By
BN-251 HPLC 5.2% QA Team

Annexure-4: Degradation Product Identification Log

Degradation Product Toxicity Risk Regulatory Limit Reviewed By
Impurity X Low Below Limit QA Team

Annexure-5: Degradation Study Corrective Action Log

Issue Identified Corrective Action Implementation Date Approved By
Degradation Above Limit Formulation Change 08/02/2025 Anjali Sharma

12. Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma
01/01/2025 V 2.0 Updated degradation study parameters GMP Compliance Anjali Sharma
]]>
Aerosol: SOP for Checking Propellant Loss in Stored Aerosol Products – V 2.0 https://www.pharmasop.in/aerosol-sop-for-checking-propellant-loss-in-stored-aerosol-products-v-2-0/ Fri, 25 Jul 2025 09:13:00 +0000 https://www.pharmasop.in/?p=8867 Read More “Aerosol: SOP for Checking Propellant Loss in Stored Aerosol Products – V 2.0” »

]]>
Aerosol: SOP for Checking Propellant Loss in Stored Aerosol Products – V 2.0

Procedure for Monitoring Propellant Loss in Stored Aerosol Products

Department Aerosol
SOP No. SOP/Aerosol/196/2025
Supersedes SOP/Aerosol/196/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a systematic approach for checking and monitoring propellant loss in stored aerosol products to ensure product stability, efficacy, and compliance with regulatory requirements.

2. Scope

This SOP applies to all aerosol products stored under controlled conditions, including batch stability studies and routine storage monitoring.

3. Responsibilities

  • Quality Control (QC) Analysts: Responsible for conducting propellant loss testing.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving test results.
  • Warehouse Team: Responsible for ensuring proper storage conditions.
  • Regulatory Affairs Team: Responsible for ensuring compliance with storage stability regulations.

4. Accountability

The Quality Control Manager is accountable for ensuring proper monitoring of propellant loss and compliance with stability requirements.

5. Procedure

5.1. Sample Selection and Storage Conditions

  1. Select aerosol cans from different production batches.
  2. Store them under standard and accelerated stability conditions (e.g., 25°C/60% RH, 40°C/75% RH).
  3. Record details in the Propellant Stability Sample Log (Annexure-1).

5.2. Initial Weight Measurement

  1. Weigh each selected aerosol container before storage.
  2. Record initial weights in the Initial Weight Log (Annexure-2).

5.3. Periodic Weight Monitoring

  1. Weigh stored samples at predefined intervals (e.g., 1 month, 3 months, 6 months).
  2. Compare the recorded weights with initial measurements.
  3. Record weight changes in the Propellant Loss Monitoring Log (Annexure-3).

5.4. Propellant Leakage Testing

  1. Perform leakage testing using gas chromatography or pressure decay methods.
  2. Identify cans with significant loss (>2% of initial weight).
  3. Document findings in the Propellant Leakage Test Log (Annexure-4).

5.5. Corrective Actions for High Propellant Loss

  1. Investigate the root cause (e.g., valve defects, improper crimping).
  2. Implement corrective actions such as improved sealing or formulation adjustments.
  3. Record corrective measures in the Propellant Loss Corrective Action Log (Annexure-5).

6. Abbreviations

  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • RH: Relative Humidity
  • SOP: Standard Operating Procedure

7. Documents

  1. Propellant Stability Sample Log (Annexure-1)
  2. Initial Weight Log (Annexure-2)
  3. Propellant Loss Monitoring Log (Annexure-3)
  4. Propellant Leakage Test Log (Annexure-4)
  5. Propellant Loss Corrective Action Log (Annexure-5)

8. References

  • Good Manufacturing Practice (GMP) Guidelines
  • ICH Q1A Stability Testing Guidelines
  • FDA Aerosol Product Stability Requirements

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Propellant Stability Sample Log

Batch No. Sample ID Storage Condition Checked By
BN-240 SPL-301 25°C/60% RH QA Team

Annexure-2: Initial Weight Log

Sample ID Initial Weight (g) Weighed By Date
SPL-301 150.5 QA Team 07/02/2025

Annexure-3: Propellant Loss Monitoring Log

Sample ID Time Point Weight (g) Change (%) Reviewed By
SPL-301 3 Months 149.8 -0.46% QA Team

Annexure-4: Propellant Leakage Test Log

Sample ID Test Method Leakage Detected Reviewed By
SPL-302 Gas Chromatography No QA Team

Annexure-5: Propellant Loss Corrective Action Log

Issue Identified Corrective Action Implementation Date Approved By
Excessive Propellant Loss Valve Redesign 08/02/2025 Anjali Sharma

12. Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma
01/01/2025 V 2.0 Updated monitoring procedures GMP Compliance Anjali Sharma
]]>
Aerosol: SOP for Propellant Compatibility Testing with Container Materials – V 2.0 https://www.pharmasop.in/aerosol-sop-for-propellant-compatibility-testing-with-container-materials-v-2-0/ Thu, 24 Jul 2025 12:23:00 +0000 https://www.pharmasop.in/?p=8866 Read More “Aerosol: SOP for Propellant Compatibility Testing with Container Materials – V 2.0” »

]]>
Aerosol: SOP for Propellant Compatibility Testing with Container Materials – V 2.0

Procedure for Propellant Compatibility Testing with Aerosol Container Materials

Department Aerosol
SOP No. SOP/Aerosol/195/2025
Supersedes SOP/Aerosol/195/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a validated procedure for assessing the compatibility of propellants with aerosol container materials to prevent degradation, contamination, or loss of product integrity.

2. Scope

This SOP applies to all propellant-container combinations used in aerosol formulations, including aluminum, tinplate, stainless steel, and coated containers.

3. Responsibilities

  • Quality Control (QC) Analysts: Responsible for performing compatibility testing.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving test results.
  • Research and Development (R&D) Team: Responsible for developing compatibility study protocols.
  • Regulatory Affairs Team: Responsible for ensuring compliance with global safety and material compatibility standards.

4. Accountability

The Quality Control Manager is accountable for ensuring the accuracy, reliability, and documentation of compatibility testing.

5. Procedure

5.1. Selection of Test Samples

  1. Select representative propellant and container samples for testing.
  2. Ensure containers are free from surface defects or pre-existing corrosion.
  3. Record sample details in the Propellant-Container Selection Log (Annexure-1).

5.2. Accelerated Compatibility Testing

  1. Fill containers with propellant and store them at controlled conditions (e.g., 40°C, 75% RH).
  2. Conduct periodic visual inspections for corrosion, swelling, or discoloration.
  3. Record findings in the Accelerated Compatibility Test Log (Annexure-2).

5.3. Chemical Interaction Analysis

  1. Analyze container material for leachable substances using GC-MS.
  2. Test propellant composition before and after exposure to the container.
  3. Record analytical results in the Chemical Interaction Report (Annexure-3).

5.4. Mechanical Integrity Testing

  1. Evaluate container pressure retention over time.
  2. Conduct burst pressure testing to assess structural integrity.
  3. Record test results in the Mechanical Integrity Test Log (Annexure-4).

5.5. Risk Assessment and Conclusion

  1. Compare findings against predefined acceptance criteria.
  2. Identify potential risks such as corrosion, leachables, or loss of pressure.
  3. Document final conclusions in the Compatibility Study Report (Annexure-5).

6. Abbreviations

  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • GC-MS: Gas Chromatography-Mass Spectrometry
  • RH: Relative Humidity
  • SOP: Standard Operating Procedure

7. Documents

  1. Propellant-Container Selection Log (Annexure-1)
  2. Accelerated Compatibility Test Log (Annexure-2)
  3. Chemical Interaction Report (Annexure-3)
  4. Mechanical Integrity Test Log (Annexure-4)
  5. Compatibility Study Report (Annexure-5)

8. References

  • Good Manufacturing Practice (GMP) Guidelines
  • ISO 10993 – Biocompatibility Testing for Materials
  • FDA Guidelines on Aerosol Propellant Compatibility

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Propellant-Container Selection Log

Propellant Type Container Material Batch No. Checked By
HFA-134a Aluminum PC-101 QA Team

Annexure-2: Accelerated Compatibility Test Log

Sample ID Storage Condition Observation Period Reviewed By
PC-101 40°C, 75% RH 30 Days QA Team

Annexure-3: Chemical Interaction Report

Propellant Type Leachable Detected Regulatory Limit Approved By
HFA-152a None Below Limit QA Team

Annexure-4: Mechanical Integrity Test Log

Container Type Initial Pressure (PSI) Final Pressure (PSI) Reviewed By
Aluminum 120 118 QA Team

Annexure-5: Compatibility Study Report

Propellant Type Container Material Compatibility Status Approved By
HFA-134a Aluminum Compatible QA Team

12. Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma
01/01/2025 V 2.0 Updated compatibility test parameters GMP Compliance Anjali Sharma
]]>
Aerosol: SOP for Determining Spray Angle and Coverage of Aerosols – V 2.0 https://www.pharmasop.in/aerosol-sop-for-determining-spray-angle-and-coverage-of-aerosols-v-2-0/ Wed, 23 Jul 2025 15:33:00 +0000 https://www.pharmasop.in/?p=8865 Read More “Aerosol: SOP for Determining Spray Angle and Coverage of Aerosols – V 2.0” »

]]>
Aerosol: SOP for Determining Spray Angle and Coverage of Aerosols – V 2.0

Procedure for Determining Spray Angle and Coverage of Aerosol Products

Department Aerosol
SOP No. SOP/Aerosol/194/2025
Supersedes SOP/Aerosol/194/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a validated method for measuring the spray angle and coverage of aerosol products to ensure uniform dispersion and product efficacy.

2. Scope

This SOP applies to all aerosol formulations tested for spray pattern, angle, and coverage within the Quality Control (QC) laboratory and during in-process monitoring.

3. Responsibilities

  • Quality Control (QC) Analysts: Responsible for conducting spray angle and coverage tests.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving test results.
  • Laboratory Supervisor: Responsible for ensuring compliance with the validated test method.
  • Production Team: Responsible for providing representative samples for testing.

4. Accountability

The Quality Control Manager is accountable for ensuring the accuracy and reliability of spray angle and coverage testing.

5. Procedure

5.1. Sample Preparation

  1. Randomly select aerosol cans from the batch.
  2. Ensure cans are conditioned at room temperature before testing.
  3. Record sample details in the Spray Test Sample Log (Annexure-1).

5.2. Spray Angle Measurement

  1. Use a calibrated spray pattern analysis system or a protractor-based setup.
  2. Spray the aerosol onto a flat surface from a standard distance (e.g., 15 cm).
  3. Measure the angle of dispersion from the central axis.
  4. Record results in the Spray Angle Test Log (Annexure-2).

5.3. Spray Coverage Assessment

  1. Apply spray to a pre-marked surface with grid lines.
  2. Allow the formulation to settle and measure the coverage area.
  3. Compare the results against product specifications.
  4. Record measurements in the Spray Coverage Test Log (Annexure-3).

5.4. Data Analysis and Acceptance Criteria

  1. Compare test results with predefined specifications.
  2. Identify any deviations and assess potential impact on product performance.
  3. Document findings in the Spray Performance Report (Annexure-4).

5.5. Corrective Actions for Non-Conforming Results

  1. Investigate root causes for abnormal spray angles or uneven coverage.
  2. Recommend corrective actions such as valve adjustment or formulation modification.
  3. Document corrective measures in the Spray Test Corrective Action Log (Annexure-5).

6. Abbreviations

  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • SOP: Standard Operating Procedure

7. Documents

  1. Spray Test Sample Log (Annexure-1)
  2. Spray Angle Test Log (Annexure-2)
  3. Spray Coverage Test Log (Annexure-3)
  4. Spray Performance Report (Annexure-4)
  5. Spray Test Corrective Action Log (Annexure-5)

8. References

  • Good Manufacturing Practice (GMP) Guidelines
  • ISO Standards for Aerosol Spray Performance
  • FDA Guidelines on Aerosol Dispersion Testing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Spray Test Sample Log

Batch No. Sample ID Test Date Analyst
BN-235 SPL-201 07/02/2025 Rahul Mehta

Annexure-2: Spray Angle Test Log

Sample ID Spray Distance (cm) Spray Angle (°) Checked By
SPL-201 15 cm 45° QA Team

Annexure-3: Spray Coverage Test Log

Sample ID Coverage Area (cm²) Test Method Reviewed By
SPL-202 120 cm² Grid Marking QA Team

Annexure-4: Spray Performance Report

Batch No. Test Parameter Specification Result Approved By
BN-236 Spray Angle 40°-50° 45° QA Team

Annexure-5: Spray Test Corrective Action Log

Issue Identified Corrective Action Implementation Date Approved By
Spray Angle Out of Range Valve Adjustment 08/02/2025 Anjali Sharma

12. Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma
01/01/2025 V 2.0 Updated spray testing parameters GMP Compliance Anjali Sharma
]]>
Aerosol: SOP for Conducting Extractables and Leachables Testing – V 2.0 https://www.pharmasop.in/aerosol-sop-for-conducting-extractables-and-leachables-testing-v-2-0/ Tue, 22 Jul 2025 18:43:00 +0000 https://www.pharmasop.in/?p=8864 Read More “Aerosol: SOP for Conducting Extractables and Leachables Testing – V 2.0” »

]]>
Aerosol: SOP for Conducting Extractables and Leachables Testing – V 2.0

Procedure for Extractables and Leachables Testing in Aerosol Products

Department Aerosol
SOP No. SOP/Aerosol/193/2025
Supersedes SOP/Aerosol/193/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a systematic approach for conducting extractables and leachables (E&L) testing in aerosol products to ensure product safety and compliance with regulatory guidelines.

2. Scope

This SOP applies to all aerosol formulations where packaging components (valves, actuators, containers, etc.) may interact with the drug product, leading to potential contamination.

3. Responsibilities

  • Quality Control (QC) Analysts: Responsible for conducting E&L testing.
  • Quality Assurance (QA) Team: Responsible for reviewing test results and approving compliance.
  • Laboratory Supervisor: Responsible for ensuring E&L testing follows validated procedures.
  • Regulatory Affairs Team: Responsible for ensuring compliance with global regulatory standards.

4. Accountability

The Quality Control Manager is accountable for ensuring the accuracy and compliance of extractables and leachables testing.

5. Procedure

5.1. Selection of Test Components

  1. Identify primary and secondary packaging components for E&L testing.
  2. Record test components in the E&L Component Selection Log (Annexure-1).

5.2. Extractables Testing

  1. Perform solvent extraction using water, ethanol, and hexane.
  2. Analyze extracted substances using GC-MS and LC-MS.
  3. Record results in the Extractables Test Log (Annexure-2).

5.3. Leachables Testing

  1. Store aerosol samples at accelerated stability conditions.
  2. Periodically analyze leachables using validated methods.
  3. Record test results in the Leachables Test Log (Annexure-3).

5.4. Data Analysis and Regulatory Comparison

  1. Compare detected substances with regulatory limits (USP, ICH guidelines).
  2. Identify any toxicological risks based on exposure limits.
  3. Document findings in the E&L Analysis Report (Annexure-4).

5.5. Corrective Actions for Non-Compliant Findings

  1. Investigate the source of leachables exceeding limits.
  2. Recommend alternative packaging materials if required.
  3. Record corrective actions in the E&L Corrective Action Log (Annexure-5).

6. Abbreviations

  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • GC-MS: Gas Chromatography-Mass Spectrometry
  • LC-MS: Liquid Chromatography-Mass Spectrometry
  • USP: United States Pharmacopeia
  • ICH: International Council for Harmonisation

7. Documents

  1. E&L Component Selection Log (Annexure-1)
  2. Extractables Test Log (Annexure-2)
  3. Leachables Test Log (Annexure-3)
  4. E&L Analysis Report (Annexure-4)
  5. E&L Corrective Action Log (Annexure-5)

8. References

  • Good Manufacturing Practice (GMP) Guidelines
  • ICH Q3C and Q3D Guidelines on Impurities
  • USP <1663> & <1664> on Extractables and Leachables

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: E&L Component Selection Log

Component Name Material Type Test Required Approved By
Valve Metal Extractables & Leachables QA Team

Annexure-2: Extractables Test Log

Component Solvent Used Extracted Compounds Reviewed By
Container Ethanol Residual Plasticizers QA Team

Annexure-3: Leachables Test Log

Sample ID Storage Condition Leachables Detected Reviewed By
BN-230 Accelerated None QA Team

Annexure-4: E&L Analysis Report

Component Detected Substance Regulatory Limit Approved By
Valve BPA Below Limit QA Team

Annexure-5: E&L Corrective Action Log

Issue Identified Corrective Action Implementation Date Approved By
Leachable exceeded limit Changed packaging material 08/02/2025 Anjali Sharma

12. Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma
01/01/2025 V 2.0 Updated E&L test parameters GMP Compliance Anjali Sharma
]]>
Aerosol: SOP for Validating Analytical Methods for Aerosol Dosage Forms – V 2.0 https://www.pharmasop.in/aerosol-sop-for-validating-analytical-methods-for-aerosol-dosage-forms-v-2-0/ Mon, 21 Jul 2025 21:53:00 +0000 https://www.pharmasop.in/?p=8863 Read More “Aerosol: SOP for Validating Analytical Methods for Aerosol Dosage Forms – V 2.0” »

]]>
Aerosol: SOP for Validating Analytical Methods for Aerosol Dosage Forms – V 2.0

Procedure for Validation of Analytical Methods for Aerosol Dosage Forms

Department Aerosol
SOP No. SOP/Aerosol/192/2025
Supersedes SOP/Aerosol/192/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a systematic approach for validating analytical methods used in aerosol dosage forms to ensure accuracy, reliability, and compliance with regulatory standards.

2. Scope

This SOP applies to all analytical methods used in the Quality Control (QC) laboratory for the testing of aerosol formulations, including assay, content uniformity, spray performance, and impurity analysis.

3. Responsibilities

  • Quality Control (QC) Analysts: Responsible for performing validation studies.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving validation protocols and reports.
  • Laboratory Supervisor: Responsible for ensuring compliance with regulatory guidelines.
  • Regulatory Affairs Team: Responsible for ensuring validated methods meet regulatory requirements.

4. Accountability

The Quality Control Manager is accountable for the validation of analytical methods and ensuring compliance with industry standards.

5. Procedure

5.1. Preparation of Validation Protocol

  1. Define the analytical method to be validated.
  2. Prepare a validation protocol covering accuracy, precision, linearity, specificity, and robustness.
  3. Record validation protocol details in the Method Validation Protocol Log (Annexure-1).

5.2. Execution of Validation Studies

  1. Conduct validation trials using representative aerosol formulations.
  2. Perform triplicate analysis for each parameter.
  3. Record experimental conditions in the Validation Study Log (Annexure-2).

5.3. Data Analysis and Statistical Evaluation

  1. Analyze collected data for accuracy, repeatability, and reproducibility.
  2. Perform statistical analysis to confirm method reliability.
  3. Document findings in the Analytical Data Report (Annexure-3).

5.4. System Suitability Testing

  1. Verify instrument performance through system suitability tests.
  2. Ensure compliance with predefined system suitability criteria.
  3. Record system suitability results in the System Suitability Log (Annexure-4).

5.5. Final Validation Report and Approval

  1. Compile validation results into a comprehensive report.
  2. Review findings against regulatory guidelines.
  3. Record approval status in the Validation Summary Report (Annexure-5).

6. Abbreviations

  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • HPLC: High-Performance Liquid Chromatography
  • UV: Ultraviolet Spectroscopy
  • SOP: Standard Operating Procedure

7. Documents

  1. Method Validation Protocol Log (Annexure-1)
  2. Validation Study Log (Annexure-2)
  3. Analytical Data Report (Annexure-3)
  4. System Suitability Log (Annexure-4)
  5. Validation Summary Report (Annexure-5)

8. References

  • Good Manufacturing Practice (GMP) Guidelines
  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP and BP Guidelines on Analytical Method Validation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Method Validation Protocol Log

Method Name Parameter Evaluated Protocol No. Approved By
HPLC Assay Accuracy VAL-101 QA Team

Annexure-2: Validation Study Log

Method Name Sample ID Validation Date Performed By
UV Spectroscopy SPL-102 07/02/2025 QA Team

Annexure-3: Analytical Data Report

Batch No. Assay Result (%) Repeatability (%) Reviewed By
BN-225 99.1% 0.5% QA Team

Annexure-4: System Suitability Log

Instrument ID Tested Parameter Result Checked By
HPLC-105 Retention Time Pass QA Team

Annexure-5: Validation Summary Report

Method Name Validation Status Approval Date Approved By
HPLC Assay Validated 08/02/2025 Anjali Sharma

12. Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma
01/01/2025 V 2.0 Updated validation parameters GMP Compliance Anjali Sharma
]]>
Aerosol: SOP for Conducting Assay Testing of Active Ingredients in Aerosols – V 2.0 https://www.pharmasop.in/aerosol-sop-for-conducting-assay-testing-of-active-ingredients-in-aerosols-v-2-0/ Mon, 21 Jul 2025 01:03:00 +0000 https://www.pharmasop.in/?p=8862 Read More “Aerosol: SOP for Conducting Assay Testing of Active Ingredients in Aerosols – V 2.0” »

]]>
Aerosol: SOP for Conducting Assay Testing of Active Ingredients in Aerosols – V 2.0

Procedure for Assay Testing of Active Ingredients in Aerosol Products

Department Aerosol
SOP No. SOP/Aerosol/191/2025
Supersedes SOP/Aerosol/191/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a standardized method for conducting assay testing of active ingredients in aerosol products to ensure potency, consistency, and compliance with regulatory requirements.

2. Scope

This SOP applies to all aerosol formulations containing active pharmaceutical ingredients (APIs) and is applicable in the Quality Control (QC) laboratory.

3. Responsibilities

  • Quality Control (QC) Analysts: Responsible for performing the assay tests.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving assay test reports.
  • Laboratory Supervisor: Responsible for overseeing test procedures and ensuring compliance.
  • Production Team: Responsible for providing representative samples for testing.

4. Accountability

The Quality Control Manager is accountable for ensuring assay tests are performed accurately and consistently.

5. Procedure

5.1. Sample Collection

  1. Collect representative aerosol samples as per the approved sampling plan.
  2. Label the samples with batch number, date, and analyst details.
  3. Record sample collection details in the Sample Log (Annexure-1).

5.2. Preparation of Test Solutions

  1. Weigh a precise amount of the aerosol sample.
  2. Dissolve the active ingredient in an appropriate solvent.
  3. Prepare a standard solution for comparison.
  4. Document preparation details in the Test Preparation Log (Annexure-2).

5.3. Assay Testing Procedure

  1. Perform assay testing using a validated analytical method (e.g., HPLC, UV Spectroscopy).
  2. Run the test in triplicate for accuracy.
  3. Calculate the concentration of the active ingredient.
  4. Record assay test results in the Assay Test Log (Annexure-3).

5.4. Data Analysis and Acceptance Criteria

  1. Compare test results with specified limits (e.g., 95%–105% of label claim).
  2. Ensure all test values fall within acceptable range.
  3. Document findings in the Assay Results Report (Annexure-4).

5.5. Handling Out-of-Specification (OOS) Results

  1. Initiate an investigation if results are out of specification.
  2. Repeat testing as per standard OOS procedures.
  3. Record investigation details in the OOS Report (Annexure-5).

6. Abbreviations

  • API: Active Pharmaceutical Ingredient
  • QC: Quality Control
  • QA: Quality Assurance
  • HPLC: High-Performance Liquid Chromatography
  • UV: Ultraviolet Spectroscopy
  • OOS: Out of Specification

7. Documents

  1. Sample Log (Annexure-1)
  2. Test Preparation Log (Annexure-2)
  3. Assay Test Log (Annexure-3)
  4. Assay Results Report (Annexure-4)
  5. OOS Report (Annexure-5)

8. References

  • Good Manufacturing Practice (GMP) Guidelines
  • Pharmacopeial Standards (USP/BP/IP)
  • FDA Guidelines on Analytical Method Validation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Sample Log

Batch No. Sample ID Collection Date Analyst
BN-220 SPL-101 07/02/2025 Rahul Mehta

Annexure-2: Test Preparation Log

Sample ID Solvent Used Concentration Prepared Prepared By
SPL-101 Methanol 10 mg/mL QA Team

Annexure-3: Assay Test Log

Sample ID Method Used Assay Result (%) Tested By
SPL-101 HPLC 99.2% QA Team

Annexure-4: Assay Results Report

Batch No. Label Claim (%) Test Result (%) Approved By
BN-221 100% 99.2% QA Team

Annexure-5: OOS Report

Batch No. OOS Result Investigation Status Reviewed By
BN-222 92% Under Investigation QA Team

12. Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma
01/01/2025 V 2.0 Updated assay procedures GMP Compliance Anjali Sharma
]]>